Background: This study examines effects of mobility and multimorbidity on hospitalization and inpatient and postacute care (PAC) facility days among older men.
Methods: Prospective study of 1,701 men (mean age 79.3 years) participating in Osteoporotic Fractures in Men (MrOS) Study Year 7 (Y7) examination (2007-2008) linked with their Medicare claims. At Y7, mobility ascertained by usual gait speed and categorized as poor, intermediate, or good. Multimorbidity quantified by applying Elixhauser algorithm to inpatient and outpatient claims and categorized as none, mild-moderate, or high. Hospitalizations and PAC facility stays ascertained during 12 months following Y7.
Results: Reduced mobility and greater multimorbidity burden were independently associated with a higher risk of inpatient and PAC facility utilization, after accounting for each other and traditional indicators. Adjusted mean total facility days per year were 1.13 (95% confidence interval [CI] = 0.74-1.40) among men with good mobility increasing to 2.43 (95% CI = 1.17-3.84) among men with poor mobility, and 0.67 (95% CI = 0.38-0.91) among men without multimorbidity increasing to 2.70 (95% CI = 1.58-3.77) among men with high multimorbidity. Men with poor mobility and high multimorbidity had a ninefold increase in mean total facility days per year (5.50, 95% CI = 2.78-10.87) compared with men with good mobility without multimorbidity (0.59, 95% CI = 0.37-0.95).
Conclusions: Among older men, mobility limitations and multimorbidity were independent predictors of higher inpatient and PAC utilization after considering each other and conventional predictors. Marked combined effects of reduced mobility and multimorbidity burden may be important to consider in clinical decision-making and planning health care delivery strategies for the growing aged population.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132118 | PMC |
| http://dx.doi.org/10.1093/gerona/glx128 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist.
Lancet Rheumatol
December 2024
Division of Rheumatic Diseases, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Division of Rheumatology, Dallas Veterans Affairs Medical Center, Veterans Affairs North Texas Health Care System, Dallas, TX, USA. Electronic address:
The global population is ageing and the rheumatology workforce should be prepared to take care of the inevitable complexities of ageing patients. We can learn from our colleagues and experts in geriatrics about how best to manage multimorbidity, polypharmacy, geriatric syndromes, and shifting priorities of older patients in the context of delivering care for rheumatic diseases. One approach to learning and adopting key ageing constructs within rheumatology practice is to incorporate the established Geriatric 5Ms-principles fundamental to caring for older adults.
View Article and Find Full Text PDFChange in frailty among older COVID-19 survivors.
J Am Geriatr Soc
December 2024
VA Puget Sound Healthcare System, Seattle, Washington, USA.
Article Synopsis
- COVID-19 survivors, particularly older adults, experience increased frailty, which can lead to new medical conditions and functional impairments.
- A study involving over 91,000 older Veterans showed that those who had COVID-19 developed significantly more health deficits in the year following infection compared to uninfected controls.
- The most common new health issues identified were fatigue, anemia, muscle atrophy, gait abnormalities, and arthritis, indicating long-term health risks associated with COVID-19.
Prediction of COVID-19 in-hospital mortality in older patients using artificial intelligence: a multicenter study.
Front Aging
October 2024
Geriatria, Accettazione Geriatrica e Centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy.
Article Synopsis
- - The study explores in-hospital mortality risk factors for older patients (60+) during the COVID-19 pandemic, emphasizing the ongoing impact of COVID-19 as endemic disease, particularly for those with multiple health issues.
- - Utilizing data from the Gerocovid-acute wards, researchers incorporated 71 variables into a machine learning platform to identify key prognostic factors affecting mortality, avoiding selection bias and enabling extensive model testing.
- - The analysis revealed that, alongside traditional health metrics, pre-COVID-19 mobility emerged as a critical predictor of in-hospital mortality, highlighting its importance in risk assessment for older patients.
Multidomain Intervention for the Reversal of Cognitive Frailty Using a Personalized Approach (AGELESS Trial): Recruitment and Baseline Characteristics of Participants.
J Prev Alzheimers Dis
October 2024
Suzana Shahar, Centre for Healthy Ageing and Wellness (HCARE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia,
Article Synopsis
- The AGELESS Trial was a study in Malaysia to see if a special program could help older adults with cognitive frailty, which is a risk for dementia.
- They wanted to learn about the people who joined the study to understand better who is at risk and willing to take part.
- The trial included 957 older adults, with about 39% having cognitive frailty, showing that these participants often had less education and lower cognitive abilities.
Biomarkers of local inflammation at the skin's surface may predict both pressure and diabetic foot ulcers.
J Wound Care
September 2024
St. James's Hospital, Dublin, Ireland.
This commentary considers the similarities which exist between pressure ulcers (PUs) and diabetic foot ulcers (DFUs). It aims to describe what is known to be shared-both in theory and practice-by these wound types. It goes on to detail the literature surrounding the role of inflammation in both wound types.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!